Mechanisms for inhibition of hepatitis B virus gene expression and replication by hepatitis C virus core protein. 2003

Shiow-Yi Chen, and Chih-Fei Kao, and Chun-Ming Chen, and Chwen-Ming Shih, and Ming-Jen Hsu, and Chi-Hong Chao, and Shao-Hung Wang, and Li-Ru You, and Yan-Hwa Wu Lee
Institute of Biochemistry and Institute of Microbiology and Immunology, National Yang-Ming University, Taipei, Taiwan 112, Republic of China.

We have demonstrated previously that the core protein of hepatitis C virus (HCV) exhibits suppression activity on gene expression and replication of hepatitis B virus (HBV). Here we further elucidated the suppression mechanism of HCV core protein. We demonstrated that HCV core protein retained the inhibitory effect on HBV gene expression and replication when expressed as part of the full length of HCV polyprotein. Based on the substitution mutational analysis, our results suggested that mutation introduced into the bipartite nuclear localization signal of the HCV core protein resulted in the cytoplasmic localization of core protein but did not affect its suppression ability on HBV gene expression. Mutational studies also indicated that almost all dibasic residue mutations within the N-terminal 101-amino acid segment of the HCV core protein (except Arg(39)-Arg(40)) impaired the suppression activity on HBV replication but not HBV gene expression. The integrity of Arg residues at positions 101, 113, 114, and 115 was found to be essential for both suppressive effects, whereas the Arg residue at position 104 was important only in the suppression of HBV gene expression. Moreover, our results indicated that the suppression on HBV gene expression was mediated through the direct interaction of HCV core protein with the trans-activator HBx protein, whereas the suppression of HBV replication involved the complex formation between HBV polymerase (pol) and the HCV core protein, resulting in the structural incompetence for the HBV pol to bind the package signal and consequently abolished the formation of the HBV virion. Altogether, this study suggests that these two suppression effects on HBV elicited by the HCV core protein likely depend on different structural context but not on nuclear localization of the core protein, and the two effects can be decoupled as revealed by its differential targets (HBx or HBV pol) on these two processes of the HBV life cycle.

UI MeSH Term Description Entries
D007150 Immunohistochemistry Histochemical localization of immunoreactive substances using labeled antibodies as reagents. Immunocytochemistry,Immunogold Techniques,Immunogold-Silver Techniques,Immunohistocytochemistry,Immunolabeling Techniques,Immunogold Technics,Immunogold-Silver Technics,Immunolabeling Technics,Immunogold Silver Technics,Immunogold Silver Techniques,Immunogold Technic,Immunogold Technique,Immunogold-Silver Technic,Immunogold-Silver Technique,Immunolabeling Technic,Immunolabeling Technique,Technic, Immunogold,Technic, Immunogold-Silver,Technic, Immunolabeling,Technics, Immunogold,Technics, Immunogold-Silver,Technics, Immunolabeling,Technique, Immunogold,Technique, Immunogold-Silver,Technique, Immunolabeling,Techniques, Immunogold,Techniques, Immunogold-Silver,Techniques, Immunolabeling
D011993 Recombinant Fusion Proteins Recombinant proteins produced by the GENETIC TRANSLATION of fused genes formed by the combination of NUCLEIC ACID REGULATORY SEQUENCES of one or more genes with the protein coding sequences of one or more genes. Fusion Proteins, Recombinant,Recombinant Chimeric Protein,Recombinant Fusion Protein,Recombinant Hybrid Protein,Chimeric Proteins, Recombinant,Hybrid Proteins, Recombinant,Recombinant Chimeric Proteins,Recombinant Hybrid Proteins,Chimeric Protein, Recombinant,Fusion Protein, Recombinant,Hybrid Protein, Recombinant,Protein, Recombinant Chimeric,Protein, Recombinant Fusion,Protein, Recombinant Hybrid,Proteins, Recombinant Chimeric,Proteins, Recombinant Fusion,Proteins, Recombinant Hybrid
D012097 Repressor Proteins Proteins which maintain the transcriptional quiescence of specific GENES or OPERONS. Classical repressor proteins are DNA-binding proteins that are normally bound to the OPERATOR REGION of an operon, or the ENHANCER SEQUENCES of a gene until a signal occurs that causes their release. Repressor Molecules,Transcriptional Silencing Factors,Proteins, Repressor,Silencing Factors, Transcriptional
D002213 Capsid The outer protein protective shell of a virus, which protects the viral nucleic acid. Capsids are composed of repeating units (capsomers or capsomeres) of CAPSID PROTEINS which when assembled together form either an icosahedral or helical shape. Procapsid,Prohead,Capsids,Procapsids,Proheads
D006511 Hepatitis B Antigens Antigens of the virion of the HEPATITIS B VIRUS or the Dane particle, its surface (HEPATITIS B SURFACE ANTIGENS), core (HEPATITIS B CORE ANTIGENS), and other associated antigens, including the HEPATITIS B E ANTIGENS. HBAg,Hepatitis B Antigen,Antigen, Hepatitis B,Antigens, Hepatitis B,B Antigen, Hepatitis,B Antigens, Hepatitis
D006515 Hepatitis B virus The type species of the genus ORTHOHEPADNAVIRUS which causes human HEPATITIS B and is also apparently a causal agent in human HEPATOCELLULAR CARCINOMA. The Dane particle is an intact hepatitis virion, named after its discoverer. Non-infectious spherical and tubular particles are also seen in the serum. Dane Particle,Hepatitis Virus, Homologous Serum,B virus, Hepatitis,Hepatitis B viruses,Particle, Dane,viruses, Hepatitis B
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001120 Arginine An essential amino acid that is physiologically active in the L-form. Arginine Hydrochloride,Arginine, L-Isomer,DL-Arginine Acetate, Monohydrate,L-Arginine,Arginine, L Isomer,DL Arginine Acetate, Monohydrate,Hydrochloride, Arginine,L Arginine,L-Isomer Arginine,Monohydrate DL-Arginine Acetate
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated

Related Publications

Shiow-Yi Chen, and Chih-Fei Kao, and Chun-Ming Chen, and Chwen-Ming Shih, and Ming-Jen Hsu, and Chi-Hong Chao, and Shao-Hung Wang, and Li-Ru You, and Yan-Hwa Wu Lee
October 1993, Journal of virology,
Shiow-Yi Chen, and Chih-Fei Kao, and Chun-Ming Chen, and Chwen-Ming Shih, and Ming-Jen Hsu, and Chi-Hong Chao, and Shao-Hung Wang, and Li-Ru You, and Yan-Hwa Wu Lee
June 2010, Virus research,
Shiow-Yi Chen, and Chih-Fei Kao, and Chun-Ming Chen, and Chwen-Ming Shih, and Ming-Jen Hsu, and Chi-Hong Chao, and Shao-Hung Wang, and Li-Ru You, and Yan-Hwa Wu Lee
May 2013, Molecular therapy : the journal of the American Society of Gene Therapy,
Shiow-Yi Chen, and Chih-Fei Kao, and Chun-Ming Chen, and Chwen-Ming Shih, and Ming-Jen Hsu, and Chi-Hong Chao, and Shao-Hung Wang, and Li-Ru You, and Yan-Hwa Wu Lee
August 2008, World journal of gastroenterology,
Shiow-Yi Chen, and Chih-Fei Kao, and Chun-Ming Chen, and Chwen-Ming Shih, and Ming-Jen Hsu, and Chi-Hong Chao, and Shao-Hung Wang, and Li-Ru You, and Yan-Hwa Wu Lee
June 2008, Journal of virological methods,
Shiow-Yi Chen, and Chih-Fei Kao, and Chun-Ming Chen, and Chwen-Ming Shih, and Ming-Jen Hsu, and Chi-Hong Chao, and Shao-Hung Wang, and Li-Ru You, and Yan-Hwa Wu Lee
June 1999, Science in China. Series C, Life sciences,
Shiow-Yi Chen, and Chih-Fei Kao, and Chun-Ming Chen, and Chwen-Ming Shih, and Ming-Jen Hsu, and Chi-Hong Chao, and Shao-Hung Wang, and Li-Ru You, and Yan-Hwa Wu Lee
May 2002, FEBS letters,
Shiow-Yi Chen, and Chih-Fei Kao, and Chun-Ming Chen, and Chwen-Ming Shih, and Ming-Jen Hsu, and Chi-Hong Chao, and Shao-Hung Wang, and Li-Ru You, and Yan-Hwa Wu Lee
January 2005, Antiviral chemistry & chemotherapy,
Shiow-Yi Chen, and Chih-Fei Kao, and Chun-Ming Chen, and Chwen-Ming Shih, and Ming-Jen Hsu, and Chi-Hong Chao, and Shao-Hung Wang, and Li-Ru You, and Yan-Hwa Wu Lee
April 2015, Journal of virology,
Shiow-Yi Chen, and Chih-Fei Kao, and Chun-Ming Chen, and Chwen-Ming Shih, and Ming-Jen Hsu, and Chi-Hong Chao, and Shao-Hung Wang, and Li-Ru You, and Yan-Hwa Wu Lee
February 1999, Journal of medical virology,
Copied contents to your clipboard!